Preconceptional primary human cytomegalovirus infection and risk of congenital infection
- PMID: 16479511
- DOI: 10.1086/500509
Preconceptional primary human cytomegalovirus infection and risk of congenital infection
Abstract
The risk of vertical transmission of human cytomegalovirus (HCMV) was investigated in 14 women who had primary HCMV infection 2-18 weeks before their last menstrual period during 2001-2004. One (8.3%) of 12 newborns examined at birth was found to be subclinically infected. Preconceptional primary HCMV infection has a transmission rate that is significantly higher than that observed in an unselected newborn population but significantly lower than that associated with maternal infection during pregnancy. Although a safe time interval between primary infection and initiation of pregnancy still needs to be defined, documented information can now be provided during counseling.
Similar articles
-
Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections.J Infect Dis. 2002 Aug 15;186(4):553-7. doi: 10.1086/341831. Epub 2002 Jul 19. J Infect Dis. 2002. PMID: 12195384
-
Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease.BJOG. 2005 Feb;112(2):166-72. doi: 10.1111/j.1471-0528.2004.00328.x. BJOG. 2005. PMID: 15663580
-
[Cytomegalovirus infection in pregnancy].Orv Hetil. 2009 May 24;150(21):963-8. doi: 10.1556/OH.2009.28614. Orv Hetil. 2009. PMID: 19443304 Review. Hungarian.
-
[The epidemiological study on human cytomegalovirus infection of pregnant women and the maternal-fetal transmission in three Chinese metropolis].Zhonghua Fu Chan Ke Za Zhi. 1996 Dec;31(12):714-7. Zhonghua Fu Chan Ke Za Zhi. 1996. PMID: 9387510 Chinese.
-
Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.Rev Med Virol. 2007 Jul-Aug;17(4):253-76. doi: 10.1002/rmv.535. Rev Med Virol. 2007. PMID: 17579921 Review.
Cited by
-
Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection.J Virol. 2013 Oct;87(20):10968-79. doi: 10.1128/JVI.01120-13. Epub 2013 Jul 31. J Virol. 2013. PMID: 23903847 Free PMC article.
-
A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System.J Neuroimmune Pharmacol. 2019 Dec;14(4):578-594. doi: 10.1007/s11481-019-09878-7. Epub 2019 Sep 11. J Neuroimmune Pharmacol. 2019. PMID: 31512166 Free PMC article. Review.
-
MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a.J Virol. 2015 Jan 15;89(2):1070-82. doi: 10.1128/JVI.01740-14. Epub 2014 Nov 5. J Virol. 2015. PMID: 25378484 Free PMC article.
-
Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.Front Immunol. 2021 Sep 8;12:730765. doi: 10.3389/fimmu.2021.730765. eCollection 2021. Front Immunol. 2021. PMID: 34566995 Free PMC article. Review.
-
Prevention of maternal cytomegalovirus infection: current status and future prospects.Int J Womens Health. 2010 Aug 9;2:23-35. doi: 10.2147/ijwh.s5782. Int J Womens Health. 2010. PMID: 21072294 Free PMC article.